Boston IVF Chief Scientific Officer Denny Sakkas, PhD, has been honored with the 2025 American Society for Reproductive Medicine (ASRM) Distinguished Researcher Award — one of the highest recognitions in reproductive medicine. This award celebrates Dr. Sakkas’ groundbreaking research and lifelong dedication to advancing the science of fertility care worldwide. 

Read the official press release on BusinessWire 

A Lifetime of Impact in Fertility Research

For more than four decades, Dr. Sakkas has been a driving force in shaping the understanding and practice of modern IVF. His pioneering studies have transformed how fertility specialists approach sperm DNA damage, fertilization, embryo development, and male infertility — leading to new scientific insights and better clinical outcomes for patients. 

Most recently, his innovative work in live imaging of human embryos has provided a deeper understanding of embryo metabolism and cell development, helping clinics worldwide refine embryo selection and improve IVF success rates.

A Global Leader and Mentor in Reproductive Science

Recognized internationally for his leadership, Dr. Sakkas has directed IVF laboratories across Europe, the UK, and the United States, and currently serves as Chief Scientific Officer at Boston IVF and IVIRMA North America, as well as Associate Professor at Yale University School of Medicine.

“Dr. Sakkas’ decades-long research in human IVF has made it possible for thousands of patients worldwide to realize their dream of building a family,” said Dr. Juan A. García-Velasco, Global Chief Scientific Officer at IVI RMA Global. “His contribution to this field is transformative.”

Beyond his research, Dr. Sakkas is known for his mentorship and commitment to training the next generation of fertility scientists — inspiring countless researchers and clinicians to push the boundaries of what’s possible in reproductive medicine.

Dr. Sakkas on the Future of Fertility Science

“It’s an incredible honor to be recognized by my peers in reproductive medicine,” said Dr. Sakkas. “This field has evolved tremendously, and I remain relentlessly committed to exploring new ways to translate research into meaningful advances for patients.”

His continued dedication reflects Boston IVF’s mission to combine scientific innovation, compassionate care, and cutting-edge technology to help more individuals and families achieve their fertility goals. 

About Boston IVF

With over 150,000 babies born since 1986, Boston IVF is one of the nation’s most experienced fertility networks and a global leader in reproductive science. The organization’s research and fellowship programs have helped train many of today’s leading fertility specialists, while its innovations in IVF and laboratory science continue to shape the future of reproductive medicine.

In 2025, Boston IVF was named one of Castle Connolly’s Top 5 Private Practices for Top Doctors in Reproductive Medicine in the Nation, reflecting its ongoing excellence in both patient care and scientific advancement.